137 related articles for article (PubMed ID: 21166896)
1. A domino effect in drug action: from metabolic assault towards parasite differentiation.
Haanstra JR; Kerkhoven EJ; van Tuijl A; Blits M; Wurst M; van Nuland R; Albert MA; Michels PA; Bouwman J; Clayton C; Westerhoff HV; Bakker BM
Mol Microbiol; 2011 Jan; 79(1):94-108. PubMed ID: 21166896
[TBL] [Abstract][Full Text] [Related]
2. An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei.
de Macêdo JP; Schumann Burkard G; Niemann M; Barrett MP; Vial H; Mäser P; Roditi I; Schneider A; Bütikofer P
PLoS Pathog; 2015 May; 11(5):e1004875. PubMed ID: 25946070
[TBL] [Abstract][Full Text] [Related]
3. Anti-trypanosomal activity of cationic N-heterocyclic carbene gold(I) complexes.
Winter I; Lockhauserbäumer J; Lallinger-Kube G; Schobert R; Ersfeld K; Biersack B
Mol Biochem Parasitol; 2017 Jun; 214():112-120. PubMed ID: 28522152
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
5. Targeting pathogen metabolism without collateral damage to the host.
Haanstra JR; Gerding A; Dolga AM; Sorgdrager FJH; Buist-Homan M; du Toit F; Faber KN; Holzhütter HG; Szöör B; Matthews KR; Snoep JL; Westerhoff HV; Bakker BM
Sci Rep; 2017 Jan; 7():40406. PubMed ID: 28084422
[TBL] [Abstract][Full Text] [Related]
6. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
7. Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei.
Worthen C; Jensen BC; Parsons M
PLoS Negl Trop Dis; 2010 May; 4(5):e678. PubMed ID: 20454560
[TBL] [Abstract][Full Text] [Related]
8. Determination of antiprotozoal drug mechanisms by metabolomics approaches.
Creek DJ; Barrett MP
Parasitology; 2014 Jan; 141(1):83-92. PubMed ID: 23734876
[TBL] [Abstract][Full Text] [Related]
9. Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei.
Bakker BM; Walsh MC; ter Kuile BH; Mensonides FI; Michels PA; Opperdoes FR; Westerhoff HV
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10098-103. PubMed ID: 10468568
[TBL] [Abstract][Full Text] [Related]
10. What controls glycolysis in bloodstream form Trypanosoma brucei?
Bakker BM; Michels PA; Opperdoes FR; Westerhoff HV
J Biol Chem; 1999 May; 274(21):14551-9. PubMed ID: 10329645
[TBL] [Abstract][Full Text] [Related]
11. Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.
Vicik R; Hoerr V; Glaser M; Schultheis M; Hansell E; McKerrow JH; Holzgrabe U; Caffrey CR; Ponte-Sucre A; Moll H; Stich A; Schirmeister T
Bioorg Med Chem Lett; 2006 May; 16(10):2753-7. PubMed ID: 16516467
[TBL] [Abstract][Full Text] [Related]
12. Biotinylated probes of artemisinin with labeling affinity toward Trypanosoma brucei brucei target proteins.
Konziase B
Anal Biochem; 2015 Aug; 482():25-31. PubMed ID: 25912417
[TBL] [Abstract][Full Text] [Related]
13. The adenosine analog tubercidin inhibits glycolysis in Trypanosoma brucei as revealed by an RNA interference library.
Drew ME; Morris JC; Wang Z; Wells L; Sanchez M; Landfear SM; Englund PT
J Biol Chem; 2003 Nov; 278(47):46596-600. PubMed ID: 12972414
[TBL] [Abstract][Full Text] [Related]
14. Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18.
Haines LR; Thomas JM; Jackson AM; Eyford BA; Razavi M; Watson CN; Gowen B; Hancock RE; Pearson TW
PLoS Negl Trop Dis; 2009; 3(2):e373. PubMed ID: 19190729
[TBL] [Abstract][Full Text] [Related]
15. A new approach to chemotherapy: drug-induced differentiation kills African trypanosomes.
Wenzler T; Schumann Burkard G; Schmidt RS; Mäser P; Bergner A; Roditi I; Brun R
Sci Rep; 2016 Mar; 6():22451. PubMed ID: 26931380
[TBL] [Abstract][Full Text] [Related]
16. Parasite Polyamines as Pharmaceutical Targets.
Roberts S; Ullman B
Curr Pharm Des; 2017; 23(23):3325-3341. PubMed ID: 28571553
[TBL] [Abstract][Full Text] [Related]
17. Triazinyl derivatives that are potent inhibitors of glucose transport in Trypanosoma brucei.
Bayele HK
Parasitol Res; 2001 Nov; 87(11):911-4. PubMed ID: 11728014
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide induces oxidative stress-dependent cell death in unicellular protozoan parasite Trypanosoma brucei.
Banerjee M; Parai D; Dhar P; Roy M; Barik R; Chattopadhyay S; Mukherjee SK
Acta Trop; 2017 Dec; 176():58-67. PubMed ID: 28739368
[TBL] [Abstract][Full Text] [Related]
19. Clomipramine kills Trypanosoma brucei by apoptosis.
de Silva Rodrigues JH; Stein J; Strauss M; Rivarola HW; Ueda-Nakamura T; Nakamura CV; Duszenko M
Int J Med Microbiol; 2016 Jun; 306(4):196-205. PubMed ID: 27086198
[TBL] [Abstract][Full Text] [Related]
20. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
